LeMaitre Vascular
LMAT
150 hedge funds and large institutions have $451M invested in LeMaitre Vascular in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 19 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 46
1.95% more ownership
Funds ownership: 77.3% → 79.25% (+2%)
4% less capital invested
Capital invested by funds: $470M → $451M (-$18.9M)
3% less funds holding
Funds holding: 155 → 150 (-5)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
Top Buyers
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$5.83M |
| 2 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$3.71M |
| 3 |
Morgan Stanley
New York
|
+$3.39M |
| 4 |
Millennium Management
New York
|
+$2.91M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$2.59M |
Top Sellers
| 1 |
EIP
Epoch Investment Partners
New York
|
-$6.86M |
| 2 |
Goldman Sachs
New York
|
-$3.31M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.94M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$1.17M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.07M |
LMAT Hedge Fund Activity: Q2 2019 in Review
150 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2019, worth a combined $451M — down 4% from $470M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of LMAT and 17 opened new positions — a net loss of 2 holders — while 46 trimmed existing stakes and 62 added.
The largest buyer was Copeland Capital Management, adding an estimated $5.83M. The largest seller was Epoch Investment Partners, exiting entirely with an estimated $6.86M sold.
- 150 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2019, down from 155 in Q1 2019.
- Funds reported $451M of LeMaitre Vascular stock for Q2 2019, down 4% quarter-over-quarter.
- 17 funds opened new LeMaitre Vascular positions in Q2 2019 and 19 closed out, a net change of -2 holders.
- The largest LeMaitre Vascular buyer in Q2 2019 was Copeland Capital Management, an estimated $5.83M added.
- The largest LeMaitre Vascular seller in Q2 2019 was Epoch Investment Partners, an estimated $6.86M sold.
Based on aggregated 13F filings for Q2 2019.